Since the legalization of cannabinoids—chemical compounds found in cannabis—for medical purposes in 2001, a growing number of Canadian physicians have turned to medicinal marijuana for patients suffering from cancer and other chronic disorders such as multiple sclerosis and arthritis. Cannabinoid receptors, which bind cannabinoids, influence cognitive and physiological processes and[Read More…]
